Literature DB >> 24127914

Real world COPD: association of morning symptoms with clinical and patient reported outcomes.

Nicolas Roche1, Mark Small, Sarah Broomfield, Victoria Higgins, Ryan Pollard.   

Abstract

This research examined the prevalence of morning symptoms and their relationship with health status, exacerbations and daily activity in patients with chronic obstructive pulmonary disease (COPD). Data on 1489 patients were analysed from a European and USA sample. Results were tested for significance (p < 0.05) using Mann-Whitney and regression modelling accounting for age, gender, body mass index, comorbidities, symptom severity, smoking status and medication adherence. Morning symptoms were experienced by 39.8% of patients. Controlling for potential confounders, morning symptoms were significantly associated with higher COPD assessment test scores (p < 0.001) and exacerbation frequency (p < 0.001), more frequent worsening of symptoms without consulting a Health Care Professional (p = 0.008), and increased impact on normal daily activities (p = 0.007); and in the working population, a significantly greater impact on getting up and ready for the day (p < 0.001) and significantly more days off work per year (p < 0.001). Our research concluded that in patients with COPD, morning symptoms are associated with poorer health status, impaired daily activities and increased risk of exacerbation in affected patients compared with those patients without morning symptoms. Improved control of patients' morning symptoms may lead to substantial reduction in COPD impact and frequency of exacerbations, and enable patients to increase daily activities, particularly early morning activities. This could, in turn, enable working patients with COPD to be more productive in the workplace.

Entities:  

Mesh:

Year:  2013        PMID: 24127914     DOI: 10.3109/15412555.2013.844784

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  28 in total

1.  Health Status of Patients With Chronic Obstructive Pulmonary Disease by Symptom Level.

Authors:  Jessica Marvel; Tzy-Chyi Yu; Robert Wood; Victoria S Higgins; Barry J Make
Journal:  Chronic Obstr Pulm Dis       Date:  2016-05-05

2.  Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.

Authors:  Jamuna K Krishnan; Kayley M Ancy; Clara Oromendia; Katherine L Hoffman; Imaani Easthausen; Nancy K Leidy; MeiLan K Han; Russell P Bowler; Stephanie A Christenson; David J Couper; Gerard J Criner; Jeffrey L Curtis; Mark T Dransfield; Nadia N Hansel; Anand S Iyer; Robert Paine Iii; Stephen P Peters; Jadwiga A Wedzicha; Prescott G Woodruff; Karla V Ballman; Fernando J Martinez
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

Review 3.  The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.

Authors:  Jill A Ohar; James F Donohue; Selwyn Spangenthal
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

4.  Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.

Authors:  Judith J Stephenson; Qian Cai; Michelle Mocarski; Hiangkiat Tan; Jalpa A Doshi; Sean D Sullivan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-17

5.  Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.

Authors:  Chen Wang; Tieying Sun; Yijiang Huang; Michael Humphries; Lingyan Bai; Lilly Li; Qian Wang; Pearl Kho; Roz Firth; Peter D'Andrea
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-05

6.  Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.

Authors:  Marc Miravitlles; Heinrich Worth; Juan José Soler Cataluña; David Price; Fernando De Benedetto; Nicolas Roche; Nina Skavlan Godtfredsen; Thys van der Molen; Claes-Göran Löfdahl; Laura Padullés; Anna Ribera
Journal:  Respir Res       Date:  2014-10-21

7.  Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT).

Authors:  Eric D Bateman; Kenneth R Chapman; Dave Singh; Anthony D D'Urzo; Eduard Molins; Anne Leselbaum; Esther Garcia Gil
Journal:  Respir Res       Date:  2015-08-02

Review 8.  Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma.

Authors:  Alcibey Alvarado-Gonzalez; Isabel Arce
Journal:  J Clin Med Res       Date:  2015-09-25

9.  The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.

Authors:  Paul W Jones; Nancy K Leidy; Asha Hareendran; Rosa Lamarca; Ferran Chuecos; Esther Garcia Gil
Journal:  Respir Res       Date:  2016-05-23

10.  Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting.

Authors:  Peter Lange; Nina Skavlan Godtfredsen; Beata Olejnicka; Bo-Anders Paradis; Dan Curiac; Sjur Humerfelt; Gunilla Telg; Helene Nordahl Christensen; Magnus Alexander Bitsch; Elisabeth Wreford Andersen; Leif Bjermer
Journal:  Eur Clin Respir J       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.